Contravisory Investment Management’s Pfizer PFE Stock Holding History

Contravisory Investment Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.21M	Sell	299,290 -2,112	-0.7%	-$55.2K	1.27%	36
2026 Q1	$8.46M	Buy	+301,402	New	+$8.02M	1.73%	24
2023 Q1	–	Sell	-8,017	Closed	-$411K	–	354
2022 Q4	$411K	Buy	8,017 +1,208	+18%	+$57.9K	0.11%	116
2022 Q3	$298K	Buy	6,809 +85	+1%	+$4.13K	0.1%	133
2022 Q2	$353K	Buy	6,724 +382	+6%	+$19.5K	0.11%	116
2022 Q1	$328K	Buy	+6,342	New	+$329K	0.09%	148
2019 Q2	–	Sell	-1,333	Closed	-$54K	–	314
2019 Q1	$54K	Buy	1,333 +118	+10%	+$4.73K	0.02%	210
2018 Q4	$50K	Buy	1,215 +785	+183%	+$32.6K	0.02%	199
2018 Q3	$18K	Sell	430 -635	-60%	-$24.4K	0.01%	212
2018 Q2	$37K	Hold	1,065	–	–	0.01%	224
2018 Q1	$36K	Buy	1,065 +11	+1%	+$378	0.01%	220
2017 Q4	$36K	Sell	1,054 -136	-11%	-$4.64K	0.01%	218
2017 Q3	$40K	Buy	+1,190	New	+$38.2K	0.01%	210
2017 Q2	–	Sell	-120	Closed	-$4K	–	227
2017 Q1	$4K	Hold	120	–	–	﹤0.01%	236
2016 Q4	$4K	Hold	120	–	–	﹤0.01%	223
2016 Q3	$4K	Buy	+120	New	+$4.01K	﹤0.01%	218
2016 Q2	–	Sell	-61	Closed	-$2K	–	227
2016 Q1	$2K	Hold	61	–	–	﹤0.01%	174
2015 Q4	$2K	Buy	+61	New	+$1.92K	﹤0.01%	181

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Contravisory Investment Management's PFE Position: Q2 2026 in Review

Contravisory Investment Management reduced its Pfizer (PFE) stake by 0.7% in Q2 2026, selling an estimated $55.2K and leaving 299,290 shares worth $7.21M. The position accounts for 1.27% of the portfolio, ranked #36.

Contravisory Investment Management first reported a position in PFE in Q4 2015 and has held it in 18 quarters since. The position peaked at $8.46M in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Contravisory Investment Management held 299,290 shares of Pfizer worth $7.21M as of Q2 2026.
Contravisory Investment Management sold 2,112 Pfizer shares in Q2 2026, an estimated $55.2K.
Pfizer made up 1.27% of Contravisory Investment Management's portfolio in Q2 2026, its #36 holding.
Contravisory Investment Management first reported a position in Pfizer in Q4 2015 and has held it in 18 quarters since.
Contravisory Investment Management's Pfizer position peaked at $8.46M in Q1 2026.
2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Contravisory Investment Management's 13F filing for Q2 2026, filed 9 Jul 2026.